Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Castot

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Neurology(R) Neuroimmunology & Neuroinflammation|November 16, 2016
Risk of relapse after natalizumab withdrawal: Results from the French TYSEDMUS cohortCaroline Papeix, Sandra Vukusic, Romain Casey, et al.
Therapie|December 22, 2011
[National Campaign of Vaccination against the flu A (H1N1)v: National Follow-up of Pharmacovigilance]Geneviève Durrieu, Céline Caillet, Isabelle Lacroix, et al.
Drug Safety|September 13, 2012
First French experience of ADR reporting by patients after a mass immunization campaign with Influenza A (H1N1) pandemic vaccines: a comparison of reports submitted by patients and healthcare professionalsGeneviève Durrieu, Aurore Palmaro, Laure Pourcel, et al.
Pharmacoepidemiology and Drug Safety|June 25, 2013
Adverse drug reactions in patients with Alzheimer's disease and related dementia in France: a national multicentre cross-sectional studyMarie-Laure Laroche, Marie-Christine Perault-Pochat, Isabelle Ingrand, et al.
Plos One|January 10, 2014
Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: a multinational self-controlled case series in EuropeSilvana Romio, Daniel Weibel, Jeanne P Dieleman, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Neurology(R) Neuroimmunology & Neuroinflammation|November 16, 2016
Risk of relapse after natalizumab withdrawal: Results from the French TYSEDMUS cohortCaroline Papeix, Sandra Vukusic, Romain Casey, et al.
Therapie|December 22, 2011
[National Campaign of Vaccination against the flu A (H1N1)v: National Follow-up of Pharmacovigilance]Geneviève Durrieu, Céline Caillet, Isabelle Lacroix, et al.
Drug Safety|September 13, 2012
First French experience of ADR reporting by patients after a mass immunization campaign with Influenza A (H1N1) pandemic vaccines: a comparison of reports submitted by patients and healthcare professionalsGeneviève Durrieu, Aurore Palmaro, Laure Pourcel, et al.
Pharmacoepidemiology and Drug Safety|June 25, 2013
Adverse drug reactions in patients with Alzheimer's disease and related dementia in France: a national multicentre cross-sectional studyMarie-Laure Laroche, Marie-Christine Perault-Pochat, Isabelle Ingrand, et al.
Plos One|January 10, 2014
Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: a multinational self-controlled case series in EuropeSilvana Romio, Daniel Weibel, Jeanne P Dieleman, et al.
Pageof 2